146 Chapter 6 22. Zaborin A, Smith D, Garfield K et al. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. MBio 2014; 5: e01361-01314. 23. Buelow E, Bello González TDJ, Fuentes S et al. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects. Microbiome 2017; 5: 88. 24. Krezalek MA, DeFazio J, Zaborina O et al. The Shift of an intestinal ‘microbiome’ to a ‘pathobiome’ governs the course and outcome of sepsis following surgical injury. Shock 2016; 45: 475–82. 25. Ojima M, Motooka D, Shimizu K et al. Metagenomic analysis reveals dynamic changes of whole gut microbiota in the acute phase of intensive care unit patients. Dig Dis Sci 2016; 61: 1628–34. 26. Hotterbeekx A, Xavier BB, Bielen K et al. The endotracheal tube microbiome associated with Pseudomonas aeruginosa or Staphylococcus epidermidis. Sci Rep 2016; 6: 36507. 27. Akrami K, Sweeney DA. The microbiome of the critically ill patient. Curr Opin Crit Care 2018; 24: 49–54. 28. Yeh A, Rogers MB, Firek B et al. Dysbiosis across multiple body sites in critically ill adult surgical patients. Shock 2016; 46: 649–54. 29. Wischmeyer PE, McDonald D, Knight R. Role of the microbiome, probiotics, and ‘dysbiosis therapy’ in critical illness. Curr Opin Crit Care 2016; 22: 347–53. 30. Dickson RP. The microbiome and critical illness. Lancet Respir Med 2016; 4: 59–72. 31. Lankelma JM, Birnie E, Weehuizen TAF et al. The gut microbiota as a modulator of innate immunity during melioidosis. PLoS Neglect Trop D 2017; 11: e0005548. 32. Deriu E, Boxx GM, He X et al. Influenza virus affects intestinal microbiota and secondary salmonella infection in the gut through Type I interferons. PLoS Pathog 2016; 12: e1005572. 33. Winglee K, Eloe-Fadrosh E, Gupta S et al. Aerosol Mycobacterium tuberculosis infection causes rapid loss of diversity in gut microbiota. PLoS ONE 2014; 9: e97048. 34. Arboleya S, Binetti A, Salazar N et al. Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol Ecol 2012; 79: 763–72. 35. Holmes E, Loo RL, Stamler J et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008; 453: 396–400. 36. Smith MI, Yatsunenko T, Manary MJ et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013; 339: 548–54. 37. Stefka AT, Feehley T, Tripathi P et al. Commensal bacteria protect against food allergen sensitization. Proc Natl Acad Sci USA 2014; 111: 13145–50. 38. Hsiao EY, McBride SW, Hsien S et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013; 155: 1451–63. 39. Langdon A, Crook N, Dantas G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med 2016; 8: 39. 40. Almagor J, Temkin E, Benenson I et al. The impact of antibiotic use on transmission of resistant bacteria in hospitals: Insights from an agent-based model. PLoS ONE 2018; 13: e0197111. 41. Graffunder EM, Preston KE, Evans AM et al. Risk factors associated with extendedspectrum beta-lactamase-producing organisms at a tertiary care hospital. J Antimicrob Chemoth 2005; 56: 139–45. 42. Alexander VN, Northrup V, Bizzarro MJ. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 2011; 159: 392–7. 43. Gibson MK, Wang B, Ahmadi S et al. Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome. Nat Microbiol 2016; 1: 16024.
RkJQdWJsaXNoZXIy MTk4NDMw